Back to results
CompletedPhase 2

A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes

NCT00675857

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Calgary, Alberta, Canada

+20 additional locations

View on ClinicalTrials.gov
A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes — TrialFind